Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2008 1
2009 1
2010 2
2011 2
2012 2
2013 1
2014 2
2015 3
2016 3
2017 2
2018 3
2019 6
2020 8
2021 11
2022 15
2023 9
2024 13
2025 14
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Aug;131(8):914-926. doi: 10.1016/j.ophtha.2024.02.014. Epub 2024 Feb 19. Ophthalmology. 2024. PMID: 38382813 Free article. Clinical Trial.
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Comparison of Endophthalmitis Rates Between Prefilled Syringes and Standard Vials in Aflibercept Intravitreal Injections: A Retrospective Study in Japan.
Morioka M, Takamura Y, Yoshida S, Mori J, Sawada T, Matsubara H, Kusuhara S, Murakami T, Kato A, Tabuchi H, Nagasato D, Ueda T, Shimura M, Hirano T, Jujo T, Mitamura Y, Nishigaki M, Harimoto K, Sasaki M, Inatani M. Morioka M, et al. Among authors: matsubara h. J Clin Med. 2025 Apr 6;14(7):2491. doi: 10.3390/jcm14072491. J Clin Med. 2025. PMID: 40217940 Free PMC article.
Predictors of Disengagement and Loss to Follow-Up of Intravitreal Injection for Neovascular Age-Related Macular Degeneration in a Real-World Clinical Setting: Post Hoc Analysis of the Multicenter Survey from the Japanese Clinical Retinal Study (J-CREST) Group.
Imazeki M, Takeuchi M, Yasukawa T, Terasaki H, Yamamoto Y, Jujo T, Wakuta M, Matsubara H, Mitamura Y, Kato A, Kondo M, Kimura K, Takagi H, Gomi F, Sakamoto T; Japanese Clinical Retinal Study (J-CREST) Group. Imazeki M, et al. Among authors: matsubara h. J Clin Med. 2025 Mar 7;14(6):1803. doi: 10.3390/jcm14061803. J Clin Med. 2025. PMID: 40142610 Free PMC article.
Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyes.
Murao F, Yanai R, Kusuhara S, Abe Y, Shimura M, Ohara H, Terasaki H, Sugimoto M, Matsubara H, Hirano Y, Kinoshita T, Tsujinaka H, Seki K, Iwase T, Mitamura Y; J-CREST. Murao F, et al. Among authors: matsubara h. Sci Rep. 2025 Oct 21;15(1):36628. doi: 10.1038/s41598-025-20300-6. Sci Rep. 2025. PMID: 41120399 Free PMC article.
Factors that contribute to loss to follow-up in the medium term after initiation of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration in Japanese patients.
Sugisawa T, Gomi F, Harada Y, Imaizumi H, Aoki S, Miki A, Kishi M, Yamauchi T, Nagasato D, Ozawa Y, Haruta M, Kato N, Matsubara H, Yasukawa T, Kato A, Terasaki H, Hirano T, Iesato Y, Tsujinaka H, Murakami T, Mitamura Y, Wakuta M, Kimura K, Shimura M; J-CREST (Japan Clinical Retina Study) Group. Sugisawa T, et al. Among authors: matsubara h. PLoS One. 2025 Jun 11;20(6):e0325963. doi: 10.1371/journal.pone.0325963. eCollection 2025. PLoS One. 2025. PMID: 40498743 Free PMC article.
Efficacy of vitrectomy combined with and without cataract surgery for diabetic macular edema: one-year follow-up multi-center study in Japan.
Yamada Y, Takamura Y, Saito K, Minamoto A, Ishigooka G, Koto T, Nakano Y, Tsuiki E, Terasaki H, Shimizu M, Kimura M, Mitamura Y, Sekine R, Mizusawa Y, Hirano T, Oyama T, Iwase T, Higashijima F, Matsubara H, Inatani M; J.-CREST (Japan Clinical REtina STudy group). Yamada Y, et al. Among authors: matsubara h. Graefes Arch Clin Exp Ophthalmol. 2025 Sep;263(9):2651-2662. doi: 10.1007/s00417-025-06845-2. Epub 2025 May 6. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 40327087 Free PMC article.
94 results